Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test?

Elisa Piva; Fulvia Chieco-Bianchi; Valentino Krajcar; Savina Aversa; Mario Plebani

首页> 外文期刊>AMERICAN JOURNAL OF HEMATOLOGY >Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test?

【24h】

Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test?

机译：利妥昔单抗联合治疗期间B细胞淋巴瘤患者的不良反应：嗜碱性粒细胞活化试验体外评估利妥昔单抗超敏反应？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

No abstract is available for this article.

机译：本文没有摘要。

著录项

来源
《AMERICAN JOURNAL OF HEMATOLOGY》 |2012年第11期|131-131|共1页
作者
Elisa Piva; Fulvia Chieco-Bianchi; Valentino Krajcar; Savina Aversa; Mario Plebani;
展开▼
作者单位

Department of Laboratory Medicine University-Hospital of Padova Padova Italy;

Division of Medical Oncology Istituto Oncologico Veneto IRCCS Padova Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Effect of rituximab combined with CVAD regimen on serum VEGF and β2-MG levels in patients with primary gastrointestinal B-cell lymphoma [J] . Shi-Tong Zhang, Ai-Min Wang, Zhi-Hui Sun, 海南医科大学学报（英文版） . 2019,第012期

机译：利妥昔单抗联合CVAD方案对原发性胃肠道B细胞淋巴瘤患者血清VEGF和β2-MG水平的影响
2. Effect of rituximab combined with CVAD regimen on serum VEGF and β2-MG levels in patients with primary gastrointestinal B-cell lymphoma [J] . Shi-Tong Zhang, Ai-Min Wang, Zhi-Hui Sun, 海南医科大学学报(英文版) . 2019,第012期

机译：利妥昔单抗联合CVAD方案对原发性胃肠道B细胞淋巴瘤患者血清VEGF和β2-MG水平的影响
3. Efficacy and safety analysis of rituximab combined with chemotherapy in the treatment of B-cell lymphoma patients complicated with hepatitis B virus infection [J] . Wang S., Zhang Z., Cai H., Indian journal of cancer. . 2016,第3期

机译：利妥昔单抗联合化疗治疗B细胞淋巴瘤患者乙型肝炎病毒感染的疗效和安全分析
4. Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma [C] . Bohua Li, Hao Wang, Yajun Guo, International conference of molecular simulations and applied informatics technologies . 2012

机译：具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Is there a relationship between the infusion-related reaction and effect of rituximab in the treatment of patients with diffuse large B-cell lymphoma? [O] . Sang-Gon Park 2019

机译：弥漫性大B细胞淋巴瘤患者的输注相关反应与利妥昔单抗的疗效之间是否存在关系？
7. Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test. [O] . Piva E, Chieco-Bianchi F, Krajcar V, 2012

机译：利妥昔单抗联合治疗期间B细胞淋巴瘤患者的不良反应：通过嗜碱性粒细胞活化试验体外评估利妥昔单抗超敏反应。

Adverse reactions in patients with B-cell lymphomas during combined treatment with rituximab: In vitro evaluation of rituximab hypersensitivity by basophil activation test?

摘要

著录项

相似文献

相关主题

期刊订阅